Apothecary Capital - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $92,782.51 -2.32%
Ethereum $3,361.90 +3.30%
BNB $685.86 +6.49%
Optimism $1.84 +6.47%
Arbitrum $0.78 +6.50%
Solana $189.21 +5.97%
Polygon $0.49 +4.24%
Cosmos $6.73 +6.22%
Avalanche $37.50 +3.86%

Bitcoin $92,782.51 -2.32%
Ethereum $3,361.90 +3.30%
BNB $685.86 +6.49%
Optimism $1.84 +6.47%
Arbitrum $0.78 +6.50%
Solana $189.21 +5.97%
Polygon $0.49 +4.24%
Cosmos $6.73 +6.22%
Avalanche $37.50 +3.86%

Apothecary Capital

investment firm

Summary
Investments
Exits
Employees

About

Apothecary Capital is an Illinois-based venture capital firm that provides financial advisory services.

Chicago,Illinois,United States

Highlights

Lead Investments

Employee Profiles

Details

Operating Status: Active
Investor Type: Venture Capital

Investments

Number of Investments

Number of Lead Investments

5

1

Apothecary Capital has made 5 investments. Their most recent investment was on Jul 1, 2008, when Portola Pharmaceuticals raised $60.09M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Jul 1, 2008 Portola Pharmaceuticals	Series C	$60.09M	Biopharma	—
May 19, 2008 Kythera Biopharmaceuticals	Series C	$30M	Biopharma	—
Dec 21, 2007 Cogentus Pharmaceuticals	Series C	$62.50M	Biotechnology	—
Jan 8, 2007 Calypso Medical	Series D	$42.20M	Health Care	Yes
Feb 17, 2005 FibroGen	Series Unknown	$100M	Biopharma	—

Employee Profiles

Number of Employee Profiles

1

Apothecary Capital has 1 current employee profiles, including Executive Alan M. Sebulsky

Alan M. Sebulsky

Executive

Exits

Apothecary Capital has had 4 exits. Apothecary Capital most notable exits include FibroGen , Portola Pharmaceuticals

Date	Company Name	Exit Type	Industry
Nov 21, 2014	FibroGen	IPO	Biopharma	Detail
May 23, 2013	Portola Pharmaceuticals	M&A	Biopharma	Detail
Oct 11, 2012	Kythera Biopharmaceuticals	M&A	Biopharma	Detail
Sep 19, 2011	Calypso Medical	M&A	Health Care	Detail